Evidence on Spironolactone Safety in COVID-19 Reassuring Evidence on Spironolactone Safety in COVID-19 Reassuring

Spironolactone and other androgen blockers might actually protect against the virus,   according to a report in the Journal of the American Academy of Dermatology.Medscape Medical News
Source: Medscape Internal Medicine Headlines - Category: Internal Medicine Tags: Dermatology News Source Type: news